These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20333656)

  • 1. Intravascular ultrasound optimization of drug-eluting stents: still not enough data.
    Leesar MA
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):584-5. PubMed ID: 20333656
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-eluting stents: safe but not sufficient.
    Vogel RA
    JACC Cardiovasc Interv; 2009 Jun; 2(6):513-4. PubMed ID: 19539254
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS.
    Jakabcin J; Spacek R; Bystron M; Kvasnák M; Jager J; Veselka J; Kala P; Cervinka P
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):578-83. PubMed ID: 19902491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation drug-eluting stents and the continuous need for rapidly available real-world data.
    Mukherjee D; Moliterno DJ
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1236-9. PubMed ID: 20129550
    [No Abstract]   [Full Text] [Related]  

  • 5. The "mini-crush" technique for managing bifurcation lesions.
    Kornowski R
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):85-7. PubMed ID: 19530202
    [No Abstract]   [Full Text] [Related]  

  • 6. Bifurcation stenting: a commitment to always kiss.
    Hillegass WB
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):614-5. PubMed ID: 20333659
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-eluting stents: more dollars than sense?
    Garg S; Eisenberg MJ
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1188-9. PubMed ID: 20129544
    [No Abstract]   [Full Text] [Related]  

  • 8. Let it be, let it be.
    Butman SM
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):898. PubMed ID: 19455656
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-eluting stents for ST-segment elevation myocardial infarction: treatment of choice or is discretion the better part of valor?
    Rihal CS
    JACC Cardiovasc Interv; 2008 Jun; 1(3):233-5. PubMed ID: 19463305
    [No Abstract]   [Full Text] [Related]  

  • 10. Long stents as a risk factor for late stent thrombosis size does matter.
    Tommaso CL
    JACC Cardiovasc Interv; 2010 Apr; 3(4):390-1. PubMed ID: 20398865
    [No Abstract]   [Full Text] [Related]  

  • 11. Left main and high-risk PCI: what, exactly, is it high risk for?
    Safian RD
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):952-3. PubMed ID: 21598347
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimization of stent deployment by intravascular ultrasound.
    Yoon HJ; Hur SH
    Korean J Intern Med; 2012 Mar; 27(1):30-8. PubMed ID: 22403496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provisional side-branch stenting in distal left main lesions: one-size-may-not-fit-all.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 May; 77(6):773-4. PubMed ID: 21520379
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-eluting stents and glycoprotein IIb/IIIa inhibitors in vessels at low anatomic risk: a retrospective analysis of previously published data from the Basel Stent Kosten Effektivitäts Trial.
    Jeger RV; Brunner-La Rocca HP; Hunziker PR; Tsakiris DA; Kaiser CA; Pfisterer ME;
    Clin Ther; 2009 Dec; 31(12):2886-93. PubMed ID: 20110027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Each generation improves on the last (in cardiology): Bayesian thinking, the randomized clinical trial, and directed evolution.
    Morrison DA
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):1018-9. PubMed ID: 21598353
    [No Abstract]   [Full Text] [Related]  

  • 16. Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.
    Beijk MA; Klomp M; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; Tijssen JG; Piek JJ; de Winter RJ
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):189-95. PubMed ID: 21542109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. It's not the dye, but the "die" in dialysis: which coronary revascularization strategy really is best?
    Butman SM
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):949-50. PubMed ID: 21108371
    [No Abstract]   [Full Text] [Related]  

  • 18. Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents.
    Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Cheong SS; Kim JJ; Park SW; Park SJ
    JACC Cardiovasc Interv; 2008 Oct; 1(5):494-503. PubMed ID: 19463351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More openness and a little less strut: two good ideas for stents and the people who implant them.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):652-3. PubMed ID: 20976746
    [No Abstract]   [Full Text] [Related]  

  • 20. Late clinical events after drug-eluting stents: the interplay between stent-related and natural history-driven events.
    Leon MB; Allocco DJ; Dawkins KD; Baim DS
    JACC Cardiovasc Interv; 2009 Jun; 2(6):504-12. PubMed ID: 19539253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.